ArticleGynecologic oncology2018

The BET inhibitor INCB054329 reduces homologous recombination efficiency and augments PARP inhibitor activity in ovarian cancer.

Andrew J Wilson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.